Regulation & law · 30/11/2018Updated: 10/17/2026 · 1 min read
Modernizing Part D and Medicare Advantage To Lower Drug Prices and Reduce Out-of-Pocket Expenses
Summary
The proposed rule aims to lower drug prices and reduce out-of-pocket expenses for Medicare Advantage and Part D enrollees by amending regulations to support health and drug plans' negotiations with pharmaceutical companies.
Original source language: Federal Register — All DocumentsOpen original release →